Premium
The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
Author(s) -
Benwell Maureen E.M.,
Balfour David J.K.
Publication year - 1992
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1992.tb09067.x
Subject(s) - nucleus accumbens , nicotine , dopamine , neuroscience , medicine , pharmacology , anesthesia , psychology
1 The effects of acute and subchronic nicotine and (+)‐amphetamine on the extracellular levels of dopamine and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in nucleus accumbens (NAc) have been studied in conscious, freely‐moving rats by use of in vivo microdialysis. 2 In rats which had been habituated to the test apparatus for approximately 80 min, the acute subcutaneous (s.c.) administration of nicotine (0.1 or 0.4 mg kg −1 ) caused a dose‐dependent increase ( P < 0.01) in spontaneous activity and evoked significant increases ( P < 0.05) in the extracellular levels of DOPAC and HVA. 3 Measurements made 24 h after the last injection of nicotine showed that pretreatment with the higher doses tested (0.4 mg kg −1 ) resulted in increased basal levels of dopamine ( P < 0.01) and decreased basal levels of DOPAC ( P < 0.05) in the NAc dialysates. 4 Pretreatment with nicotine (0.1 or 0.4 mg kg −1 daily for 5 days) enhanced the effects of the drug on spontaneous locomotor activity and enhanced the effects of the drug on extracellular levels of dopamine to the extent that the response became significant ( P < 0.05). 5 If a dopamine uptake inhibitor, nomifensine, was added to the Ringer solution used to dialyse the probe, the s.c. administration of both acute and subchronic nicotine (0.4 mg kg −1 ) resulted in significant increases ( P < 0.05) in the dopamine concentration in the dialysate. Under these conditions, pretreatment with nicotine prior to the test day prolonged ( P < 0.05) the dopamine response to a challenge dose of nicotine. 6 Subcutaneous injections of (+)‐amphetamine (0.2 or 0.5 mg kg −1 ) evoked dose‐dependent increases in both spontaneous activity and the concentration of dopamine in NAc dialysates. These responses were unaffected by 5 days pretreatment with the drug. 7 The results of this study support the conclusion that the enhanced locomotor response to nicotine observed in animals pretreated with the drug prior to the test day is associated with potentiation of its effects on dopamine secretion in the NAc.